These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 30220117

  • 1. [Prognostic significance of combined TERT and IDH gene mutation analysis in diffusely infiltrating gliomas].
    Liu QQ, Yin XX, Zou Y, Yu TP, Gong J, Chen XQ, Nie L, Xu M, Zhang MN, Zhou Q, Chen N.
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep 08; 47(9):658-663. PubMed ID: 30220117
    [Abstract] [Full Text] [Related]

  • 2. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
    Arita H, Matsushita Y, Machida R, Yamasaki K, Hata N, Ohno M, Yamaguchi S, Sasayama T, Tanaka S, Higuchi F, Iuchi T, Saito K, Kanamori M, Matsuda KI, Miyake Y, Tamura K, Tamai S, Nakamura T, Uda T, Okita Y, Fukai J, Sakamoto D, Hattori Y, Pareira ES, Hatae R, Ishi Y, Miyakita Y, Tanaka K, Takayanagi S, Otani R, Sakaida T, Kobayashi K, Saito R, Kurozumi K, Shofuda T, Nonaka M, Suzuki H, Shibuya M, Komori T, Sasaki H, Mizoguchi M, Kishima H, Nakada M, Sonoda Y, Tominaga T, Nagane M, Nishikawa R, Kanemura Y, Kuchiba A, Narita Y, Ichimura K.
    Acta Neuropathol Commun; 2020 Nov 23; 8(1):201. PubMed ID: 33228806
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
    Jain S, Gupta P, Shankar KB, Singh R, Siraj F.
    J Cancer Res Ther; 2023 Nov 23; 19(3):562-566. PubMed ID: 37470575
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma].
    Pan Y, Qi XL, Wang LM, Dong RF, Zhang M, Zheng DF, Chang Q, Zhong YF.
    Zhonghua Bing Li Xue Za Zhi; 2013 May 23; 42(5):292-8. PubMed ID: 24004584
    [Abstract] [Full Text] [Related]

  • 6. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.
    Vuong HG, Altibi AMA, Duong UNP, Ngo HTT, Pham TQ, Chan AK, Park CK, Fung KM, Hassell L.
    Crit Rev Oncol Hematol; 2017 Dec 23; 120():1-9. PubMed ID: 29198322
    [Abstract] [Full Text] [Related]

  • 7. Clinical implications of molecular analysis in diffuse glioma stratification.
    Mizoguchi M, Hata N, Kuga D, Hatae R, Akagi Y, Sangatsuda Y, Fujioka Y, Takigawa K, Funakoshi Y, Suzuki SO, Iwaki T.
    Brain Tumor Pathol; 2021 Jul 23; 38(3):210-217. PubMed ID: 34268651
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.
    Makino Y, Arakawa Y, Yoshioka E, Shofuda T, Minamiguchi S, Kawauchi T, Tanji M, Kanematsu D, Nonaka M, Okita Y, Kodama Y, Mano M, Hirose T, Mineharu Y, Miyamoto S, Kanemura Y.
    BMC Cancer; 2021 Sep 15; 21(1):1025. PubMed ID: 34525976
    [Abstract] [Full Text] [Related]

  • 10. TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.
    Chan AK, Yao Y, Zhang Z, Chung NY, Liu JS, Li KK, Shi Z, Chan DT, Poon WS, Zhou L, Ng HK.
    Mod Pathol; 2015 Feb 15; 28(2):177-86. PubMed ID: 25081751
    [Abstract] [Full Text] [Related]

  • 11. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
    Ferreira MSV, Sørensen MD, Pusch S, Beier D, Bouillon AS, Kristensen BW, Brümmendorf TH, Beier CP, Beier F.
    J Neurooncol; 2020 Mar 15; 147(1):1-14. PubMed ID: 31960234
    [Abstract] [Full Text] [Related]

  • 12. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
    Kim HS, Kwon MJ, Song JH, Kim ES, Kim HY, Min KW.
    Pathol Res Pract; 2018 Jun 15; 214(6):881-888. PubMed ID: 29650441
    [Abstract] [Full Text] [Related]

  • 13. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.
    Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K.
    Acta Neuropathol; 2013 Aug 15; 126(2):267-76. PubMed ID: 23764841
    [Abstract] [Full Text] [Related]

  • 14. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    Akyerli CB, Yüksel Ş, Can Ö, Erson-Omay EZ, Oktay Y, Coşgun E, Ülgen E, Erdemgil Y, Sav A, von Deimling A, Günel M, Yakıcıer MC, Pamir MN, Özduman K.
    J Neurosurg; 2018 Apr 15; 128(4):1102-1114. PubMed ID: 28621624
    [Abstract] [Full Text] [Related]

  • 15. IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients.
    Chen N, Yu T, Gong J, Nie L, Chen X, Zhang M, Xu M, Tan J, Su Z, Zhong J, Zhou Q.
    Pathology; 2016 Dec 15; 48(7):675-683. PubMed ID: 27780605
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
    Iuchi T, Sugiyama T, Ohira M, Kageyama H, Yokoi S, Sakaida T, Hasegawa Y, Setoguchi T, Itami M.
    Brain Tumor Pathol; 2018 Apr 15; 35(2):71-80. PubMed ID: 29470683
    [Abstract] [Full Text] [Related]

  • 17. The correlation analysis of TERT promoter mutations with IDH1/2 mutations and 1p/19q detected in human gliomas.
    Xu J, Xu FP, Liu ZH, Cui Q, Zhang KP, Li Z.
    Medicine (Baltimore); 2022 Jul 22; 101(29):e29668. PubMed ID: 35866817
    [Abstract] [Full Text] [Related]

  • 18. Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.
    Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, Bracci PM, Eckel-Passow JE, Lachance DH, Clarke J, Taylor JW, Luks T, Wiencke JK, Jenkins RB, Wrensch MR.
    Acta Neuropathol; 2017 Jun 22; 133(6):1001-1016. PubMed ID: 28255664
    [Abstract] [Full Text] [Related]

  • 19. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
    Petersen JK, Boldt HB, Sørensen MD, Blach S, Dahlrot RH, Hansen S, Burton M, Thomassen M, Kruse T, Poulsen FR, Andreasen L, Hager H, Ulhøi BP, Lukacova S, Reifenberger G, Kristensen BW.
    Neuropathol Appl Neurobiol; 2021 Feb 22; 47(1):108-126. PubMed ID: 32696543
    [Abstract] [Full Text] [Related]

  • 20. Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas.
    Zhang Z, Chan AK, Ding X, Li Y, Zhang R, Chen L, Liu Y, Wang Y, Xiong J, Ng HK, Yao Y, Zhou L.
    Neuro Oncol; 2017 Jul 01; 19(7):1008-1010. PubMed ID: 28874004
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.